Kisspeptin · DOSSIER

Kisspeptin

Kisspeptin-10 · Metastin · Peptide · 10 AS
LEGAL DE · NOT APPROVEDEVIDENCE · EARLY CLINICAL STUDIES3 STUDIES
FIG.01 — SIGNAL CHAIN
YNWNSFGLRF-NH₂ (Kisspeptin-10) · ~1302.4 Da
02

Mechanism of action

What Kisspeptin does in the body — step by step.

01

Kisspeptin is a neuropeptide derived from the KISS1 gene, occurring in several biologically active forms (KP-10, KP-13, KP-14, KP-54).

02

It binds the G-protein-coupled receptor KISS1R (formerly GPR54) on hypothalamic GnRH neurons and is regarded as a central regulator of pulsatile GnRH release — the master pacemaker of the hypothalamic-pituitary-gonadal axis.

03

Kisspeptin mediates the activation of puberty, governs the cyclic release of LH/FSH and mediates the negative and positive feedback mechanisms of sex hormones at the hypothalamic level.

03

Research status

How far along is the evidence?

PRECLINICALEARLY CLINICAL STUDIESCLINICALLY ESTABLISHED
Kisspeptin is one of the most intensively researched reproductive-medicine peptides of the past decade.
Kisspeptin is one of the most intensively researched reproductive-medicine peptides of the past decade.
Clinical Phase II studies (particularly at Imperial College London, Abbara et al.) investigated kisspeptin-54 and -10 in hypothalamic amenorrhoea, hypogonadotropic hypogonadism and as an alternative to hCG in IVF treatment.
In these studies, kisspeptin reliably triggered the LH peak for egg maturation with a reduced risk of ovarian hyperstimulation syndrome (OHSS).
In the context of testosterone replacement therapy, kisspeptin is discussed as a means of maintaining the suppressed endogenous GnRH axis — robust RCT data for this off-label use are lacking.
04

Known risks

Without human data, safety statements are limited. What is known:

01
Flushing and mild nausea described after injection
02
Potential desensitisation with continuous administration (KISS1R downregulation)
03
Effect is strictly dose-dependent — subtherapeutic doses have no LH effect, supratherapeutic doses cause desensitisation
04
Use in existing hormone-dependent conditions (PCOS, hormone-dependent tumours) not studied
05
No long-term safety data outside reproductive-medicine study settings
05

Cited studies

Chronological — links lead to the source.

2013
Kisspeptin and reproduction: physiological roles and therapeutic possibilities
PubMed 23744387 →
2015
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization
PubMed 26239566 →
2017
Kisspeptin modulates sexual and emotional processing in the human brain
PubMed 27856795 →
06

Frequently asked questions

What is Kisspeptin?+

Kisspeptin is a neuropeptide derived from the KISS1 gene, occurring in several biologically active forms (KP-10, KP-13, KP-14, KP-54).

What type of peptide is Kisspeptin?+

Kisspeptin belongs to the Reproductive peptide class.

What is Kisspeptin used for?+

In research, Kisspeptin has primarily been investigated in the context of: Libido. These are research findings (evidence: early clinical studies), not proven benefits in humans and not a usage recommendation.

Is Kisspeptin legal in Germany?+

Kisspeptin is not approved as a medicine in Germany. Obtaining it outside clinical studies is legally problematic.

Is Kisspeptin FDA-approved / legal in the US?+

No. Kisspeptin is not FDA-approved as a drug in the US; it is mostly sold as a research chemical and not for human consumption.

Is Kisspeptin legal in Canada?+

No. Kisspeptin is not authorized by Health Canada and not intended for human consumption.

Where can I buy Kisspeptin?+

Peptica sells nothing and names no sources. Kisspeptin is "not approved" in Germany; obtaining unapproved substances outside clinical studies is illegal and carries quality and safety risks.

What is the dosage of Kisspeptin?+

Peptica publishes no dosing. There are no approved dosing guidelines for Kisspeptin; figures circulating online stem from animal studies or anecdote, not from validated human protocols. This is not medical advice.

Is Kisspeptin banned in sport (WADA)?+

Kisspeptin is currently not on the WADA Prohibited List.

What are the known risks of Kisspeptin?+

Documented risks include: Flushing and mild nausea described after injection; Potential desensitisation with continuous administration (KISS1R downregulation). This is not a complete safety assessment and not medical advice — see the risks section for the full list.

How well researched is Kisspeptin?+

The evidence is classified as “early clinical studies”. 3 studies are cited on this page.

What is the molecular weight of Kisspeptin?+

Kisspeptin has a molar mass of about 1302.4 Da.

Which peptides are related to Kisspeptin?+

Closely related entries: PT-141. A direct side-by-side comparison is available via the compare function.

07

Dossier

Legal · Structure · Sources.

LEGAL STATUS BY REGION
Germanynot approved

Kisspeptin is not an approved medicine in the EU. Clinical use occurs exclusively within regulated studies. Not on the WADA Prohibited List. Importing it as a research chemical may, depending on the context, fall under the German Medicines Act (AMG).

Legal status varies by country and can change. This is not legal advice.

STRUCTURE & MOLECULE
H₂NYNWNSFGLRF-NH (Kisspeptin-10)COOH
10
AMINO ACIDS
~1302.4
MOL. WEIGHT (Da)
Very short
HALF-LIFE
SOURCES & EXTERNAL DATABASES

Methodology: Peptica compiles publicly available studies and regulatory information and assigns each statement an evidence level. Not medical advice. No warranty.

RELATED PEPTIDES & FURTHER READING
08

Community notes

Note: These posts are user opinions and not medical advice. Posts containing dosages, therapeutic claims or purchase recommendations are removed. All entries are manually reviewed before publication.
This page is intended solely for factual, scientifically oriented information. No medical advice · no dosage or usage recommendations · no claims of efficacy · no substitute for medical consultation. Peptica sells no substances. Partner links are marked as advertising; Peptica may earn a commission. © 2026 Peptica · Issue 01